載入...
Protease inhibitors for the treatment of hepatitis C virus infection
The hepatitis C virus (HCV) has affected an estimate of 80 million individuals worldwide and is a strain of public health. Around 25–30% of patients in Europe and the US infected with HIV are coinfected with HCV. Despite treatment modalities containing a NS3/4A protease inhibitor in combination with...
Na minha lista:
| 發表在: | GMS Infect Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
German Medical Science GMS Publishing House
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301719/ https://ncbi.nlm.nih.gov/pubmed/30671330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/id000034 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|